Literature DB >> 30427544

Poor Vitamin K Status Is Associated With Low Bone Mineral Density and Increased Fracture Risk in End-Stage Renal Disease.

Pieter Evenepoel1,2, Kathleen Claes1,2, Bjorn Meijers1,2, Michaël Laurent3, Bert Bammens1,2, Maarten Naesens1,2, Ben Sprangers1,2, Hans Pottel4, Etienne Cavalier5, Dirk Kuypers1,2.   

Abstract

Chronic kidney disease and osteoporosis are major public health problems associated with an aging population. Vitamin K insufficiency is prevalent among patients with end-stage renal disease (ESRD). Preliminary data indicate that poor vitamin K status may compromise bone health and that increased inflammation may be in the causal pathway. We performed an ancillary analysis of data collected in the frame of prospective observational cohort studies exploring various aspects of bone health in de novo renal transplant recipients to investigate the association between vitamin K status, inflammation, bone mineral density, and incident clinical fractures. Parameters of mineral metabolism (including biointact PTH and FGF23, sclerostin, calcidiol, calcitriol) and inflammation (CRP and IL-6), osteoprotegerin, bone turnover markers (P1NP, BsAP, and TRAP5B), and dephosphorylated-uncarboxylated Matrix Gla Protein (dp-ucMGP) were assessed on blood samples collected immediately prior to kidney transplantation in 468 patients. Areal bone mineral density (aBMD) was measured at the lumbar spine and femoral neck by dual-energy X-ray absorptiometry within 14 days posttransplant. Poor vitamin K status, defined by dp-ucMGP >500 nmol/L, was highly prevalent (90%). High dp-ucMGP levels independently associated with elevated inflammatory markers and low aBMD. No associations were observed between vitamin K status and bone turnover markers. During a median follow-up of 5.1 years, 33 patients sustained a fragility fracture. In Cox-proportional hazards analysis, a dp-ucMGP above median associated with incident fractures, independent of classical determinants, including age, gender, history of fracture, and aBMD (HR 2.21; 95% CI, 1.00 to 4.91; p < 0.05). In conclusion, poor vitamin K status associates with inflammation and low aBMD in patients with ESRD and confers an increased risk of incident fractures in de novo renal transplant recipients.
© 2018 American Society for Bone and Mineral Research. © 2018 American Society for Bone and Mineral Research.

Entities:  

Keywords:  BIOCHEMICAL MARKERS OF BONE TURNOVER; BONE MODELING AND REMODELING; DISEASES AND DISORDERS OF/RELATED TO BONE; DXA ANALYSIS/QUANTITATION OF BONE; OSTEOPOROSIS

Mesh:

Substances:

Year:  2018        PMID: 30427544     DOI: 10.1002/jbmr.3608

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  20 in total

Review 1.  Vitamin K in CKD Bone Disorders.

Authors:  M Fusaro; G Cianciolo; P Evenepoel; L Schurgers; M Plebani
Journal:  Calcif Tissue Int       Date:  2021-01-06       Impact factor: 4.333

Review 2.  Vitamin K effects in human health: new insights beyond bone and cardiovascular health.

Authors:  Maria Fusaro; Maurizio Gallieni; Camillo Porta; Thomas L Nickolas; Pascale Khairallah
Journal:  J Nephrol       Date:  2019-12-19       Impact factor: 3.902

Review 3.  Traditional and Non-traditional Risk Factors for Osteoporosis in CKD.

Authors:  Hanne Skou Jørgensen; Karel David; Syazrah Salam; Pieter Evenepoel
Journal:  Calcif Tissue Int       Date:  2021-02-14       Impact factor: 4.333

Review 4.  Role of Vitamin K in Bone and Muscle Metabolism.

Authors:  N Alonso; A Meinitzer; E Fritz-Petrin; D Enko; M Herrmann
Journal:  Calcif Tissue Int       Date:  2022-02-12       Impact factor: 4.333

Review 5.  Dysbiosis in Patients with Chronic Kidney Disease: Let Us Talk About Vitamin K.

Authors:  Julie Ann Kemp; Livia Alvarenga; Ludmila F M F Cardozo; Lu Dai; Peter Stenvinkel; Paul G Shiels; Tilman M Hackeng; Leon J Schurgers; Denise Mafra
Journal:  Curr Nutr Rep       Date:  2022-09-23

Review 6.  Vitamin K2 Needs an RDI Separate from Vitamin K1.

Authors:  Asim Cengiz Akbulut; Angelina Pavlic; Ploingarm Petsophonsakul; Maurice Halder; Katarzyna Maresz; Rafael Kramann; Leon Schurgers
Journal:  Nutrients       Date:  2020-06-21       Impact factor: 5.717

Review 7.  The Role of Gut Dysbiosis in the Bone-Vascular Axis in Chronic Kidney Disease.

Authors:  Pieter Evenepoel; Sander Dejongh; Kristin Verbeke; Bjorn Meijers
Journal:  Toxins (Basel)       Date:  2020-04-29       Impact factor: 4.546

8.  Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug-Bug Interaction?

Authors:  Lu Dai; Björn K Meijers; Bert Bammens; Henriette de Loor; Leon J Schurgers; Abdul Rashid Qureshi; Peter Stenvinkel; Pieter Evenepoel
Journal:  Toxins (Basel)       Date:  2020-05-27       Impact factor: 4.546

Review 9.  Perspective: Evidence before Enthusiasm-A Critical Review of the Potential Cardiovascular Benefits of Vitamin K.

Authors:  M Kyla Shea; Kathleen L Berkner; Guylaine Ferland; Xueyan Fu; Rachel M Holden; Sarah L Booth
Journal:  Adv Nutr       Date:  2021-06-01       Impact factor: 8.701

10.  Vitamin K alleviates bone calcium loss caused by Salmonella Enteritidis through carboxylation of osteocalcin.

Authors:  Yaojun Liu; Rainer Mosenthin; Lihong Zhao; Jianyun Zhang; Cheng Ji; Qiugang Ma
Journal:  J Anim Sci Biotechnol       Date:  2021-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.